Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee

By sjmartinez • November 30, 2023

Bhatt SP, Casaburi R, Agusti A, Celli BR, Miller BE, Putcha N, Rommes J, Dransfield MT; Medical and Scientific Advisory Committee of the COPD Foundation. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee. Lancet Respir Med. 2023 Dec;11(12):1041-1043. doi: 10.1016/S2213-2600(23)00436-8. PMID: 38030371.

Tags: Harbor UCLA, Publications, Pulmonary, Critical Care & Sleep Medicine

Use of CT-derived non-cardiovascular calcification marker for predicting cardiovascular events among diabetic older adults: the multi-ethnic study of atherosclerosis

Ghotbi E, Bluemke DA, Hathaway QA, Klein JG, Shabani M, Akhtarkhavari S, Barr RG, Bancks MP, Post WS, Budoff M, Lima JAC, Demehri S. Use[...]

Updated Psoriasis Prevalence and Risk Factors in the United States-Insights From the 2023 NHIS

Engel P, Wu JJ. Updated Psoriasis Prevalence and Risk Factors in the United States-Insights From the 2023 NHIS. Exp Dermatol. 2025 Aug;34(8):e70146. doi: 10.1111/exd.70146. PMID:[...]

Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale[...]